TITLE

Clinical spectrum of cryoglobulinaemic neuropathy

AUTHOR(S)
Gemignani, F.; Brindani, F.; Alfieri, S.; Giuberti, T.; Allegri, I.; Ferrari, C.; Marbini, A.
PUB. DATE
October 2005
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct2005, Vol. 76 Issue 10, p1410
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and objective: Cryoglobulinaemic neuropathy (CN) is probably common, as it is usually related to HCV infection. The aim of this study was to delineate the clinical spectrum of CN in a large series and to investigate the factors influencing its expression. Methods: Seventy one consecutive patients (12 men, 59 women), diagnosed as having CN on the basis of clinical features of neuropathy, clinical and serological findings of mixed cryoglobulinaemia, and exclusion criteria, were identified during a six year period. All patients underwent clinical examination, and electrophysiological and laboratory investigations. Results: Results of the patients with "pure" CN (n = 54) and those with comorbidities (n = 17) were evaluated separately. Of the former 76% had sensory neuropathy (including selective small fibre sensory neuropathy (SFSN) in 14 patients), 15% hod sensorimotor polyneuropathy, and 9% had mononeuritis multiplex. The pattern of distribution was similar in the patients with comorbidities. In 30/54 patients, CN was the first manifestation of cryoglobulinaemia. Patients with mild cryoglobulinaemic syndrome had sensory neuropathy more frequently than patients with active syndrome (p<0.01), in particular SFSN (p<0.01). The latter group had more severe features, with significantly more cases of reduced or absent motor (p =0.028) and sensory action potentials (p<0.01), and a tendency towards higher Rankin scores (p = 0.06). Conclusions: Sensory neuropathy, often in the form of SFSN, is by far the commonest form of CN. Cryoglobulinaemia should be vigorously investigated in the diagnosis of sensory neuropathy, especially in older women. Activity of the cryoglobulinaemic syndrome is a major factor influencing the clinical expression and severity of CN.
ACCESSION #
18530737

 

Related Articles

  • Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection. Min-Suk Yoon; Obermann, Mark; Dockweiler, Christina; Assert, Roland; Canbay, Ali; Haag, Sebastian; Gerken, Guido; Diener, Hans-Christoph; Katsarava, Zaza // Journal of Neurology;Jan2011, Vol. 258 Issue 1, p80 

    There is growing evidence that hepatitis-C virus (HCV) infection might cause peripheral neuropathy. We aimed to investigate the prevalence, clinical and electrophysiological features of sensory neuropathy in patients with cryoglobulin negative HCV infection. We studied 46 consecutive...

  • Acute Inflammatory Demyelinating Polyneuropathy in Children; Clinical and Electrophysiologic Findings. Shamsabadi, Farhad Mahvelati; Karimzadeh, Parvaneh; Tonekaboni, Seyed-Hasan; Ghorobi, Javad // Iranian Journal of Pediatrics;Mar2009, Vol. 19 Issue 1, p52 

    Objective: The aim of this study was to evaluate the electrophysiologic findings of Guillain Barre Syndrome (GBS) in children and their relation with clinical progress of the disease. Methods: Twenty-three children with GBS were evaluated between 2005 and 2007. Electrophysiologic evaluations...

  • Creativity Needed in Drug Pricing, Promotion. Wechsler, Jill // Pharmaceutical Executive Global Digest;Feb2015, Vol. 35 Issue 2, p10 

    The article focuses on the controversies related to the cost of new medicines for the treatment of hepatitis C virus (HCV) patients along with the information on alternative therapies that improve the negotiating clout of pharmacy benefit managers (PBMs) and health plans, that pressurises...

  • AUTOIMMUNE HEPATITIS, HEPATITIS C, AND INTERFERON: LOOK BEFORE YOU LEAP. Shiffman, Mitchell L.; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Aug1992, Vol. 87 Issue 8, p1059 

    Describes the detection of hepatitis C virus antibody in the abscence of viral RNA in patients with autoimmune hepatitis. Evaluation of patient population; Discussion on the results of the study.

  • The Prevalence of Hepatitis C in Patients with Porphyria Cutanea Tarda in Stockholm, Sweden. Linde, Ylva; Harper, Pauline; Floderus, Ylva; Ros, Anne-Marie // Acta Dermato-Venereologica;Mar2005, Vol. 85 Issue 2, p164 

    In many countries hepatitis C virus infection has been considered a major factor triggering overt porphyria cutanea tarda. The prevalence of hepatitis C virus infection was retrospectively studied in 87 patients who during a period of 11 years were diagnosed with porphyria cutanea tarda in...

  • Fibromyalgia Symptoms and Cirrhosis. Rogal, Shari; Bielefeldt, Klaus; Wasan, Ajay; Szigethy, Eva; Lotrich, Francis; DiMartini, Andrea // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1482 

    Background: An association between fibromyalgia and hepatitis C virus (HCV) has been previously described. However, the relationship between nonalcoholic steatohepatitis (NASH) and fibromyalgia symptoms has not been assessed, though they share several risk factors. Aim: We aimed to assess the...

  • Need more surveys.  // Down to Earth;1/16/2014, Vol. 22 Issue 17, p39 

    The article focuses on a research conducted by the U.S-based nonprofit organization I-MAK, which shows that 273,000 Indians could be infected with hepatitis C virus (HCV).

  • The hepatitis C disaster. McGregor, Maurice // CMAJ: Canadian Medical Association Journal;06/02/98, Vol. 158 Issue 11, p1461 

    Editorial. Presents the author's views on the Canadian government offering financial assistance to Canadians infected by the hepatitis C virus through the blood system between January 1, 1986 and July 1, 1990. Complex problem; The possible avoidance of some of the infections; The fairness of...

  • Hepatitis C as medical misadventure. Hoey, John // CMAJ: Canadian Medical Association Journal;06/02/98, Vol. 158 Issue 11, p1463 

    Editorial. Discusses the compensation package for Canadians that were infected with Hepatitis C virus from January 1, 1986 to July 1, 1990. New Zealand's medical compensation packages; Canada's compensation plans.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics